Chester County News and Community Website
Are you looking for Chester County businesses that are traded on the Nasdaq Stock Market? Would you love adding a Chester County business to your investment portfolio or 401k? The process of building a properly diversified portfolio, which includes investments in local businesses, is an important personal financial strategy.
Here you will find news and updates from Chester County businesses that are listed on the Nasdaq Stock Market. There is a growing appetite for real, local business news about publicly traded companies. MyChesCo features local business news from around Chester County. Moreover, we provide in-depth articles about Chester County’s dynamic business and economic scene, including tips for small biz owners, marketing, management, startups, entrepreneurship, and more.
EXTON, PA — Frontage Europe, a wholly owned subsidiary of Frontage Laboratories Inc. (Nasdaq: FHL), has relocated its bioanalytical laboratory to a single, expanded facility near Milan, a move the …
Frontage Europe Consolidates Milan Lab in Bid to Speed Drug Development Read More
WEST CHESTER, PA — QVC Group, Inc. said it will report financial results for the fourth quarter of 2025 before the opening bell on Thursday, February 26, followed by a …
QVC Group Sets Feb. 26 Earnings Call as Investors Brace for 2025 Results Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (Nasdaq: ACRS) reported striking preclinical results for its experimental oral drug ATI-2138, showing rapid, near-complete, and sustained hair regrowth in a severe mouse model …
Experimental Hair-Loss Drug Sparks Rapid Regrowth in Severe Alopecia Study Read More
MALVERN, PA — Meridian Corporation (Nasdaq: MRBK) reported higher fourth-quarter earnings and raised its quarterly dividend as the community bank capped a year of sharply improved profitability, wider interest margins …
Meridian Raises Dividend as 2025 Profit Jumps 34% on Stronger Margins Read More
MALVERN, PA — TELA Bio (NASDAQ: TELA) has approved inducement equity awards for five newly hired employees, signaling continued investment in talent as the medical technology company advances its commercial-stage …
TELA Bio Grants Equity to New Hires as Medtech Growth Push Continues Read More
MALVERN, PA — On Friday, Ocugen (Nasdaq: OCGN) closed a $22.5 million registered direct stock offering, strengthening its balance sheet as the gene-therapy developer pushes forward with programs targeting blinding …
Ocugen Raises $20.9M to Extend Cash Runway Into Late 2026 Read More
EXTON, PA — Bentley Systems, Incorporated (Nasdaq: BSY) said it has repaid at maturity $678 million in principal and accrued interest on its 0.125% convertible senior notes due 2026, a …
Bentley Retires $678M Convertible Debt, Tightening Balance Sheet Read More MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) said preliminary 12-month data from its Phase 2 ArMaDa clinical trial showed meaningful reductions in disease progression for patients with geographic atrophy, a …
Ocugen (NASDAQ: OCGN) Reports Strong Midstage Data for Gene Therapy Read More WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) said it has launched a placebo-controlled Phase 1b proof-of-concept trial of ATI-052, an experimental bispecific antibody aimed at treating atopic dermatitis, marking …
Aclaris Pushes New Antibody Into Skin Disease Trial, Eyes Asthma Next Read More MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) said newly published clinical trial data support the safety and early effectiveness of its experimental gene therapy for Stargardt disease, a rare inherited …
Gene Therapy Slows Vision Loss in Stargardt Trial, Fueling Hope for First Treatment Read More